Quantcast

Latest lipidomics Stories

2014-05-27 08:29:59

Single Largest Prospective Pan-Omic Study to Identify Key Biomarkers and Central Therapeutic Targets for Cardiovascular Diseases Has Completed Enrollment RICHMOND, Va., May 27, 2014 /PRNewswire/ -- Global Genomics Group (G3), a life sciences company investigating biological networks that lead to the development of disease, today announced that it has completed the enrollment of patients in its international, prospective GLOBAL (Genetic LOci and Burden of Atherosclerotic Lesions)...

2014-04-02 04:21:25

New Software Functionality Addresses Broad Range of Proteomics, Metabolomics, and Lipidomics Applications MUNICH, April 2, 2014 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today unveiled two new data analysis software packages for proteomics and metabolomics/lipidomics analyses: Progenesis(®) QI and Progenesis QI for Proteomics. These new releases of the highly acclaimed software packages are an early result of Waters' acquisition of Nonlinear Dynamics Ltd., the world leader in...

2014-02-26 08:30:03

Single Largest Prospective Pan-Omic Study Will Investigate Blood-Based Protein Markers of Disease RICHMOND, Va. and MONTREAL, Feb. 26, 2014 /PRNewswire/ -- Global Genomics Group (G3) and Caprion Proteomics, Inc., today announced that they have entered into a collaboration agreement to investigate biological networks and pathways in order to discover novel biomarkers and pharmaceutical targets for cardiovascular diseases. Under the terms of the agreement, Caprion will identify...

2014-02-13 08:31:56

Pilot Data of Single Largest Prospective Pan-Omic Study to Identify Key Biomarkers and Central Therapeutic Targets for Cardiovascular Diseases Expected Later This Year RICHMOND, Va., Feb. 13, 2014 /PRNewswire/ -- Global Genomics Group (G3) today announced that it has completed enrollment of the 5,000-patient discovery cohort of its GLOBAL (Genetic LOci and Burden of Atherosclerotic Lesions) clinical study. Pilot data for the first cohort of patients are expected later this year....

2011-10-10 09:11:11

Could controlling cell-membrane fat play a key role in turning off disease? Researchers at the University of Illinois at Chicago think so, and a biosensor they've created that measures membrane lipid levels may open up new pathways to disease treatment. Wonhwa Cho, distinguished professor of chemistry, and his coworkers engineered a way to modify proteins to fluoresce and act as sensors for lipid levels. Their findings are reported in Nature Chemistry, online on Oct. 9. "Lipid...

2011-06-06 13:35:00

NEW YORK, June 6, 2011 /PRNewswire/ -- Lpath, Inc. (OTC: LPTN), the industry leader in lipidomics-based therapeutics, today announced that their June 2nd RetailInvestorConferences.com presentation is available for on-demand viewing. To access, follow this link: www.retailinvestorconferences.com and click on: "Register/Watch Event Now!" The archived replay of the presentation will be available for 90 days. Investors may download shareholder materials from the "virtual booth" for the next...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related